Evidence map›Paper›PMID 24785967›Full record

ArticlePediatric neurology2014

Complementary and alternative medicine for Duchenne and Becker muscular dystrophies: characteristics of users and caregivers.

Yong Zhu, Paul A Romitti, Kristin M Conway, Jennifer Andrews, Ke Liu, F John Meaney, Natalie Street, Soman Puzhankara, Charlotte M Druschel, Dennis J Matthews

Open access · greenAbstract read
In one paragraph

Article in Pediatric neurology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Yong ZhuDepartment of Epidemiology, The University of Iowa, Iowa City, Iowa.
Paul A RomittiDepartment of Epidemiology, The University of Iowa, Iowa City, Iowa. Electronic address: paul-romitti@uiowa.edu.
Kristin M ConwayDepartment of Epidemiology, The University of Iowa, Iowa City, Iowa.
Jennifer AndrewsDepartment of Pediatrics, The University of Arizona, Tucson, Arizona.
Ke LiuDepartment of Biostatistics, The University of Iowa, Iowa City, Iowa.
F John MeaneyDepartment of Pediatrics, The University of Arizona, Tucson, Arizona.
Natalie StreetNational Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.
Soman PuzhankaraDepartment of Epidemiology, The University of Iowa, Iowa City, Iowa.
Charlotte M DruschelNew York State Department of Health, Troy, New York.
Dennis J MatthewsDepartment of Physical Medicine and Rehabilitation, University of Colorado, Aurora, Colorado.
University of Iowa · USUniversity of Arizona · USNational Center on Birth Defects and Developmental Disabilities · USNew York State Department of Health · USUniversity of Colorado Denver · US

Funding

Surveillance and Epidemiologic Research of Duchenne and Becker Muscular DystrophyU01DD000189 · DD · UNIVERSITY OF IOWA · PI ROMITTI, PAUL A · 2006 to 2011
$4.1M
Comp A-MD and Neuromuscular Disorder Surveillance and Research in IowaU01DD001119 · DD · UNIVERSITY OF IOWA · PI ROMITTI, PAUL A · 2014 to 2018
$2.4M
NCBDD CDC HHS DD000189NCBDD CDC HHS U01 DD000189NCBDD CDC HHS U01 DD001119
6 · The paper itself

Abstract

backgroundComplementary and alternative medicine is frequently used in the management of chronic pediatric diseases, but little is known about its use by those with Duchenne or Becker muscular dystrophy.

methodsComplementary and alternative medicine use by male patients with Duchenne or Becker muscular dystrophy and associations with characteristics of male patients and their caregivers were examined through interviews with 362 primary caregivers identified from the Muscular Dystrophy Surveillance, Tracking, and Research Network.

resultsOverall, 272 of the 362 (75.1%) primary caregivers reported that they had used any complementary and alternative medicine for the oldest Muscular Dystrophy Surveillance, Tracking, and Research Network male in their family. The most commonly reported therapies were from the mind-body medicine domain (61.0%) followed by those from the biologically based practice (39.2%), manipulative and body-based practice (29.3%), and whole medical system (6.9%) domains. Aquatherapy, prayer and/or blessing, special diet, and massage were the most frequently used therapies. Compared with nonusers, male patients who used any therapy were more likely to have an early onset of symptoms and use a wheel chair; their caregivers were more likely to be non-Hispanic white. Among domains, associations were observed with caregiver education and family income (mind-body medicines [excluding prayer and/or blessing only] and whole medical systems) and Muscular Dystrophy Surveillance, Tracking, and Research Network site (biologically based practices and mind-body medicines [excluding prayer and/or blessing only]).

conclusionsComplementary and alternative medicine use was common in the management of Duchenne and Becker muscular dystrophies among Muscular Dystrophy Surveillance, Tracking, and Research Network males. This widespread use suggests further study to evaluate the efficacy of integrating complementary and alternative medicine into treatment regimens for Duchenne and Becker muscular dystrophies.

Indexed as

AdultCaregiversCommunity Health PlanningComplementary TherapiesHumansInterview, PsychologicalMaleMiddle AgedMuscular Dystrophy, DuchenneRetrospective StudiesYoung AdultBecker muscular dystrophycomplementary therapiesDuchenne muscular dystrophyneuromuscular diseases

Identifiers

PMID24785967
PMCPMC4467767
OpenAlexW2104733189

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.